That’s a wrap on the Cure SMA 2024 Annual SMA Conference! This year, in addition to sharing our latest data and connecting with the community, we were honored to be able to help showcase the future of accessible air travel with our friends from Delta Flight Products. Thank you to all who joined us to share your feedback and questions as we continue to help inform innovations that are equitable to travelers of various abilities. Learn more: https://ow.ly/TS8c50SfMSZ #2024SMAConference
About us
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries. For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.
- Website
-
http://www.biogen.com
External link for Biogen
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Cambridge, MA
- Type
- Public Company
Locations
-
Primary
225 Binney Street
Cambridge, MA 02142, US
-
Landis & Gyr-Strasse 3
Zug, CH 6300, CH
-
P.O. Box 14627
5000 Davis Drive
Research Triangle Park, NC 27709, US
Employees at Biogen
-
Bjoern Rosner
Digital Strategy | Innovation | Cross-functional Team Leadership | Program Management | Strategic Planning | Change Management | Data Analysis &…
-
Saleem Hussaini
Business Technology Leader | Life Sciences | @Biogen
-
Frode Hellesnes
-
Stavros Platakis
Global Head Customer Excellence and Operations BBU at Biogen
Updates
-
Our team had the pleasure of attending FARA’s CureFA Soiree in Edmond, OK, where we had the opportunity to meet with nearly 300 members of the Friedreich ataxia (FA) community. Event organizers planned an entire weekend of events for those traveling in early from out of state, including a baseball game, “Meet and Greet,” and Sunday brunch after the gala. Biogen staff are especially appreciative of the special “Meet and Greet” which provided an opportunity for our team to hear firsthand from people living with FA and their families. Learn more about Friedreich ataxia: https://ow.ly/Zf1r50Sfsv0 #FriedreichAtaxia | #TeamBiogen
-
We are honored to be recognized by the National Organization for Rare Disorders with the 2024 Industry Innovation Award for our work in Friedreich ataxia. This is proof of our commitment and capabilities to help those affected by rare and neurodegenerative diseases. Learn more: https://ow.ly/gZWM50SeFSA #RareDisease | #Innovation | #Biogen
-
We were honored to join members of the amyotrophic lateral sclerosis (ALS) community at the Muscular Dystrophy Association’s Wings Over Wall Street Gala, where we received the Diamond award for our efforts to bring the first therapy targeting a genetic cause of ALS to the community. We are grateful to be recognized alongside others who are committed to making a meaningful difference for people living with ALS. Learn more: https://ow.ly/jHf850SbIvY #ALS | #RareDisease
-
Our therapy for a rare genetic form of amyotrophic lateral sclerosis (ALS) in adults was recently approved for use in the European Union. We are proud to continue our work with the ALS community to bring an important new therapy to people living with this form of the disease. Learn more: https://ow.ly/ILA050SbGAH #Biogen | #ALS | #RareDisease
-
Last week, our teams in RTP, North Carolina, came together for an immersive experience, including an Alzheimer’s disease (AD) patient and caregiver and Biogen internal AD experts to learn more about the disease and the criticality of the work they do. Learn more about our work in Alzheimer’s disease: https://ow.ly/EyT650SaN7n #AlzheimersDisease | #AD
-
This Pride Month, we take time to celebrate the outstanding contributions of our LGBTQ+ colleagues and those who are driving progress in health equity. We believe that healthcare is more likely to meet the needs of more people when we take an inclusive approach. That’s why it’s important that Biogen be a place where everyone can thrive. We’re proud that we were named as a Human Rights Campaign’s Leader in LGBTQ+ Workplace Inclusion recipient for the 10th year in a row. Learn about Biogen’s commitment to health equity and inclusion in the workplace: https://ow.ly/FNVp50Sa0KH #PrideMonth | #CaringDeeply | #HealthEquity
-
We’re sharing our latest data in infants and toddlers with spinal muscular atrophy (SMA) at the Cure SMA Annual SMA Research and Clinical Care Meeting in Austin, presented by Crystal Proud, M.D., Pediatric Neurologist at Children’s Hospital of the King’s Daughters. Learn more: https://ow.ly/GzBp50S9ZQC #Biogen | #SpinalMuscularAtrophy | #SMA | #CureSMA | #2024SMAConference
-
Our Solothurn manufacturing facility in Switzerland is a leader in Biogen’s overall site sustainability efforts – from reducing energy use to managing organic waste to engaging the local community. Our passionate colleagues are taking actions to identify concrete ways to reduce our environmental impact. This World Environment Day, we celebrate them for taking meaningful action to protect the environment. Learn how our Solothurn site is championing sustainability: https://ow.ly/XBR850S9YBK #WorldEnvironmentDay | #Sustainability | #TeamBiogen
-
Each year we look forward to connecting with the spinal muscular atrophy (SMA) community at the Cure SMA 2024 Annual SMA Conference to hear directly from the people who inspire everything we do. Learn more about the programs and how you can join us on June 6-9 in Austin, Texas: https://ow.ly/EX2y50S8Aqh #Biogen | #SpinalMuscularAtrophy | #SMA | #CureSMA | #2024SMAConference
Affiliated pages
Similar pages
Browse jobs
Stock
BIIB
NASDAQ
20 minutes delay
$225.74
-0.24 (-0.106%)
- Open
- 225.73
- Low
- 225.31
- High
- 228.53
Data from Refinitiv
See more info on